Todd Alfred Carter, Chief Scientific Officer: Voyager Therapeutics VYGR Planned sale · Filed 02/24

Trade details

Type: Planned sale notice
Stock: Voyager Therapeutics VYGR
Person: Todd Alfred CarterChief Scientific Officer
Planned sale date: 26/02/24
Filed: 26/02/24

More to sell after $24.9K in 3 months

Voyager Therapeutics trades, last 26 weeks

What else happened in Voyager Therapeutics around then

Filed or reported within 30 days of the trade day · 01/25~03/26

Todd Alfred Carter's recent trades

Todd Alfred CarterChief Scientific Officer
Sell10b5-1 planVoyager Therapeutics
Sell10b5-1 plan
Voyager Therapeutics
VYGR
$15.7K
4,174 sh
$15.7K
Filed 02/26
Traded 02/24
Todd Alfred CarterChief Scientific Officer
Sell10b5-1 planVoyager Therapeutics
Sell10b5-1 plan
Voyager Therapeutics
VYGR
$11.4K
3,301 sh
$11.4K
Filed 02/20
Traded 02/18
Todd Alfred CarterChief Scientific Officer
Planned saleVoyager Therapeutics
Planned sale
Voyager Therapeutics
VYGR
$11.3K
3,301 sh
$11.3K
Filed 02/18
Traded 02/18
Todd Alfred CarterChief Scientific Officer
SellVoyager Therapeutics
Sell
Voyager Therapeutics
VYGR
$13.6K
3,525 sh
$13.6K
Filed 02/11
Traded 02/10
Todd Alfred CarterChief Scientific Officer
Planned saleVoyager Therapeutics
Planned sale
Voyager Therapeutics
VYGR
$13.6K
3,525 sh
$13.6K
Filed 02/10
Traded 02/10